We are live on ! Find out more
HVC

Healthcare Value Capital Portfolio holdings

AUM $50.7M
1-Year Est. Return 24.72%
This Fund
S&P 500
This Quarter Est. Return
-17.86%
1 Year Est. Return
+24.72%
3 Year Est. Return
+18.99%
5 Year Est. Return
+98.49%
10 Year Est. Return
–
AUM
$68.1M
AUM Growth
+$7.62M
Cap. Flow
+$5.55M
Cap. Flow %
8.16%
Top 10 Hldgs %
77.61%
Holding
35
New
13
Increased
4
Reduced
1
Closed
4

Top Buys

Rank Stock Value
1
ANIP icon
ANI Pharmaceuticals
ANIP
+$2.54M
2
ASRT
Assertio
ASRT
+$2.32M
3
PFE icon
Pfizer
PFE
+$753K
4
SGNT
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
+$701K
5
ARLZ
Aralez Pharmaceuticals Inc.
ARLZ
+$515K

Top Sells

Rank Stock Value
1
TWM icon
ProShares UltraShort Russell2000
TWM
+$1.14M
2
PTX
Pernix Therapeutics Holdings, Inc.
PTX
+$443K

Sector Composition

Rank Sector Weight
1 Healthcare 70.16%
2 Miscellaneous 29.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZGNX
26
DELISTED
Zogenix, Inc.
ZGNX
$294K 0.43%
31,850
– –
SRNE
27
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$269K 0.4%
50,000
– –
SEEL
28
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
– –
0
– –
QLTI
29
CALL
DELISTED
QLT Inc
QLTI
$147K 0.22%
+100,000
New +$238K
VIRX
30
CALL
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$81K 0.12%
714
– –
AMRN
31
CALL
Amarin Corp
AMRN
$297M
– –
-20,000
Closed -$756K
ANIP icon
32
CALL
ANI Pharmaceuticals
ANIP
$1.69B
– –
-25,000
Closed -$1.13M
MNKD icon
33
PUT
MannKind Corp
MNKD
$1.31B
– –
-100,000
Closed -$725K
SEEL
34
CALL
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
– –
0
– -$99K
PTX
35
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
– –
-15,000
Closed -$443K
1
2

Similar funds

C
Castlelake Minneapolis, Minnesota $48.5M AUM 87.77% 1-Year Est. Return
CC
Cedar Capital Barrington, Illinois $54.9M AUM 33.3% 1-Year Est. Return
FCOI
FirstMark Capital OF II New York $44.1M AUM 18.15% 1-Year Est. Return
FCOI
FirstMark Capital OF I New York $43.1M AUM 6.31% 1-Year Est. Return
BI
BCBSM Inc Eagan, Minnesota $42.4M AUM 0.4% 1-Year Est. Return
KC
Kelso & Company New York $42.3M AUM
SCIM
Spring Creek Investment Management Philadelphia, Pennsylvania $42.3M AUM 31.86% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

Healthcare Value Capital's Q1 2016 Portfolio in Review

As of Q1 2016, Healthcare Value Capital held 35 positions worth $68.1M, up 13% from $60.5M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Healthcare Value Capital deployed $5.55M of net new capital in Q1 2016, opening 13 new positions and adding to 4 existing holdings. Its largest new stake was SAGENT PHARMACEUTICALS INC COM STK (DE): 50,000 shares worth $609K.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, down from 85% a quarter earlier, followed by Miscellaneous.

On the sell side, the largest reduction was ProShares UltraShort Russell2000, an estimated $1.14M trimmed.

  • Healthcare Value Capital's largest Q1 2016 buy was SAGENT PHARMACEUTICALS INC COM STK (DE): 50,000 shares worth $609K.
  • Healthcare Value Capital added most to ANI Pharmaceuticals in Q1 2016, an estimated $2.54M increase.
  • Healthcare Value Capital's biggest Q1 2016 reduction was ProShares UltraShort Russell2000, cutting an estimated $1.14M.
  • Healthcare Value Capital fully exited Pernix Therapeutics Holdings, Inc. in Q1 2016, selling an estimated $443K.
  • Healthcare Value Capital's ten largest holdings make up 78% of its $68.1M portfolio in Q1 2016.
  • Healthcare Value Capital opened 13 new positions and closed 4 in Q1 2016.
  • Healthcare Value Capital's portfolio value rose 13% quarter-over-quarter to $68.1M.

Based on Healthcare Value Capital's 13F filing for Q1 2016, filed 16 May 2016.